The current kevetrin trial is for ovarian cancer.

The current kevetrin trial is for ovarian cancer. We surmise that it was the one that was most evidently affected in the Phase 1 clinical trial, so they are focusing on it as proof of concept. Cancer trials can be horrendously complex and expensive so this is a smart move to get proof of concept with a cancer that seemed to respond well. That makes it easier to get a deep-pockets partner so they can go full steam ahead after this trial.